Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 2 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Mind Medicine Inc. has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 distinct examiners and 2 distinct art units, showing a compact but divided prosecution structure.
HOERNER, PAUL ELLSWORTH is the busiest examiner, handling 3 pending matters. This concentration makes that examiner relationship central to docket planning and may permit coordinated review of recurring claim or eligibility issues.
The remaining matter is outside that examiner concentration, so counsel should preserve a separate analysis for its assigned art unit and examination record. Portfolio-level consistency is useful, but the data supports treating the concentrated group and the separate assignment as distinct workstreams.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOERNER, PAUL ELLSWORTH | 3 | 50.6% | +62.3% |
| LANE, DANIEL E | 1 | 3.8% | +8.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19171122 | SYSTEM AND METHOD FOR AUTOMATIC ANALYSIS OF TEXTS IN PSYCHOTHERAPY, COUNSELING, AND OTHER MENTAL HEALTH MANAGEMENT ACTIVITIES | LANE, DANIEL E | — |
| 19023120 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 19023132 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 18824317 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19023120 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 19023132 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| 18824317 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | — |
| Art Unit | Apps |
|---|---|
| 1611 | 3 |
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19171122 | SYSTEM AND METHOD FOR AUTOMATIC ANALYSIS OF TEXTS IN PSYCHOTHERAPY, COUNSELING, AND OTHER MENTAL HEALTH MANAGEMENT ACTIVITIES | LANE, DANIEL E | 3715 | §101§102§112 | Non-Final OA | — | Pending | Apr 04, 2025 |
| 19023120 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | 1611 | §102§103§112 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 19023132 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | 1611 | §103§112 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 18824317 | FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY | HOERNER, PAUL ELLSWORTH | 1611 | §103§112 | Non-Final OA | — | Pending | Sep 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMind Medicine Inc. has 4 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Paul Ellsworth Hoerner has the most, with 3 of Mind Medicine Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
